文献速递帕金森病与运动障碍神经免疫

病理性α-突触核蛋白在帕金森病中增强免疫激活

Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease.
PubMed 文献 · Ann Neurol · 2019-08-15

该研究探讨病理性α-突触核蛋白能否特异性触发帕金森病过度炎症反应。方法为检测原代人单核细胞和小胶质细胞系暴露于病理性α-突触核蛋白后的细胞因子释放。结果显示病理性α-突触核蛋白强烈激活免疫细胞,且帕金森病患者单核细胞呈过度激活状态。

要点

  • 病理性α-突触核蛋白可强烈激活人单核细胞和小胶质细胞系。
  • 免疫激活程度与α-突触核蛋白构象相关,纤维化和早发型突变作用最强。
  • 帕金森病患者单核细胞对病理性α-突触核蛋白呈过度激活反应。

核心结论

  • α-突触核蛋白病理与帕金森病单核细胞失调可共同导致针对α-突触核蛋白的过度炎症反应。

研究设计与样本

  • 研究评估原代人单核细胞和小胶质细胞系暴露于病理性α-突触核蛋白后的细胞因子释放。
  • 研究使用帕金森病患者与健康对照的血细胞外囊泡及小鼠模型进行验证。

主要发现

  • 病理性α-突触核蛋白(突变、聚集)引起人单核细胞和小胶质细胞BV2细胞强烈的炎症激活。
  • 免疫激活呈构象依赖性,纤维化程度增加和早发型突变对免疫激活作用最强。
  • 细胞外囊泡可增强细胞外α-突触核蛋白对免疫细胞的激活,可能通过促进α-突触核蛋白摄取实现。
  • 帕金森病患者血细胞外囊泡诱导的单核细胞激活强于健康对照。
  • 帕金森病患者单核细胞对病理性α-突触核蛋白刺激呈失调和过度活跃状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Excessive inflammation in the central nervous system (CNS) and the periphery can result in neurodegeneration and parkinsonism. Recent evidence suggests that immune responses in Parkinson disease patients are dysregulated, leading to an increased inflammatory reaction to unspecific triggers. Although α-synuclein pathology is the hallmark of Parkinson disease, it has not been investigated whether pathologic α-synuclein is a specific trigger for excessive inflammatory responses in Parkinson disease. METHODS: We investigated the immune response of primary human monocytes and a microglial cell line to pathologic forms of α-synuclein by assessing cytokine release upon exposure. RESULTS: We show that pathologic α-synuclein (mutations, aggregation) results in a robust inflammatory activation of human monocytes and microglial BV2 cells. The activation is conformation- dependent, with increasing fibrillation and early onset mutations having the strongest effect on immune activation. We also found that activation of immune cells by extracellular α-synuclein is potentiated by extracellular vesicles, possibly by facilitating the uptake of α-synuclein. Blood extracellular vesicles from Parkinson disease patients induce a stronger activation of monocytes than blood extracellular vesicles from healthy controls. Most importantly, monocytes from Parkinson disease patients are dysregulated and hyperactive in response to stimulation with pathologic α-synuclein. Furthermore, we demonstrate that α-synuclein pathology in the CNS is sufficient to induce the monocyte dysregulation in the periphery of a mouse model. INTERPRETATION: Taken together, our data suggest that α-synuclein pathology and dysregulation of monocytes in Parkinson disease can act together to induce excessive inflammatory responses to α-synuclein. ANN NEUROL 2019;86:593-606.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Grozdanov V, Bousset L, Hoffmeister M, et al. Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease. Ann Neurol. 2019. PMID: 31343083. doi:10.1002/ana.25557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。